Patents by Inventor Jacob Drew Edick
Jacob Drew Edick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240043969Abstract: The present disclosure generally relates to a magnesium alloy including about 2-7% by weight zinc; about 0.2-3% by weight calcium; about 0-1.0% by weight of an alloying element; and a balance of magnesium. The magnesium alloy may include a ternary absorption profile including a first absorption rate, second absorption rate, and third absorption rate, the second absorption rate being approximately slower than the first absorption rate and the third absorption rate. The magnesium alloy may be formed as a portion or more of a bodily implant.Type: ApplicationFiled: March 15, 2023Publication date: February 8, 2024Inventors: Jacob Drew Edick, Carolyn Joan Lahti Woldring
-
Publication number: 20210137709Abstract: A bioerodible endoprosthesis includes a bioerodible magnesium alloy. The bioerodible magnesium alloy has magnesium and one or more additional alloying elements, including aluminum. The alloy has a microstructure comprising equiaxed Mg-rich solid solution phase grains having an average grain diameter of less than or equal to 5 microns and continuous or discontinuous second-phase precipitates in grain boundaries between the Mg-rich solid solution-phase grains, the second-phase precipitates having an average longest dimension of 0.5 micron or less.Type: ApplicationFiled: January 22, 2021Publication date: May 13, 2021Inventors: Jonathan S. Stinson, Dennis A. Boismier, Jacob Drew Edick, Torsten Scheuermann, Louis Toth, Jan Weber, Charles Deng
-
Patent number: 10589005Abstract: A bioerodible endoprosthesis includes a bioerodible body including an alloy comprising at least 85 weight percent magnesium and at least one high-melting-temperature element having a melting temperature of greater than 700° C. The alloy has a microstructure including equiaxed magnesium-rich phase grains and optionally high-melting-temperature intermetallic phases. The equiaxed magnesium-rich phase grains have an average grain diameter of less than or equal to 10 microns. High-melting-temperature intermetallic phases, if present, can have an average longest dimension of 3 microns or less.Type: GrantFiled: March 11, 2016Date of Patent: March 17, 2020Assignee: Boston Scientific Scimed, Inc.Inventors: Jacob Drew Edick, Jonathan S. Stinson
-
Patent number: 10518001Abstract: A bioerodible endoprosthesis includes a bioerodible magnesium alloy including between 50 weight percent and 92 weight percent magnesium, at least 5.5 weight percent in sum of one or more elements selected from the group consisting of Ho, Er, Lu, Tb and Tm, and at least 2.0 weight percent in sum of one or more elements selected from the group consisting of Y, Nd and Gd. The bioerodible magnesium alloy has a microstructure including equiaxed Mg-rich solid solution-phase grains having an average grain diameter of less than or equal to 15 microns and second-phase precipitates and/or ceramic nanoparticles in grain boundaries between the equiaxed Mg-rich solid solution-phase grains. The secondary-phase precipitates or ceramic nanoparticles have an average longest dimension of 2.0 micron or less. The microstructure can be produced by one or more equal-channel high-strain processes.Type: GrantFiled: November 15, 2016Date of Patent: December 31, 2019Assignee: Boston Scientific Scimed, Inc.Inventor: Jacob Drew Edick
-
Patent number: 9603728Abstract: A bioerodible endoprosthesis includes a bioerodible magnesium alloy. The bioerodible magnesium alloy has a microstructure including equiaxed Mg-rich solid solution-phase grains having an average grain diameter of less than or equal to 5 microns and second-phase precipitates in grain boundaries between the equiaxed Mg-rich solid solution-phase grains. The beta-phase precipitates have an average longest dimension of 0.5 micron or less. The microstructure can be produced by one or more equal-channel high-strain processes.Type: GrantFiled: February 12, 2014Date of Patent: March 28, 2017Assignee: Boston Scientific SciMed, Inc.Inventors: Jonathan S. Stinson, Dennis A. Boismier, Jacob Drew Edick, Torsten Scheuermann, Louis Toth, Jan Webber, Charles Deng
-
Publication number: 20170072112Abstract: A bioerodible endoprosthesis includes a bioerodible magnesium alloy. The bioerodible magnesium alloy has a microstructure including equiaxed Mg-rich solid solution-phase grains having an average grain diameter of less than or equal to 5 microns and second-phase precipitates in grain boundaries between the equiaxed Mg-rich solid solution-phase grains. The beta-phase precipitates have an average longest dimension of 0.5 micron or less. The microstructure can be produced by one or more equal-channel high-strain processes.Type: ApplicationFiled: November 22, 2016Publication date: March 16, 2017Inventors: Jonathan S. Stinson, Dennis A. Boismier, Jacob Drew Edick, Torsten Scheuermann, Louis Toth, Jan Weber, Charles Deng
-
Publication number: 20170056562Abstract: A bioerodible endoprosthesis includes a bioerodible magnesium alloy including between 50 weight percent and 92 weight percent magnesium, at least 5.5 weight percent in sum of one or more elements selected from the group consisting of Ho, Er, Lu, Tb and Tm, and at least 2.0 weight percent in sum of one or more elements selected from the group consisting of Y, Nd and Gd. The bioerodible magnesium alloy has a microstructure including equiaxed Mg-rich solid solution-phase grains having an average grain diameter of less than or equal to 15 microns and second-phase precipitates and/or ceramic nanoparticles in grain boundaries between the equiaxed Mg-rich solid solution-phase grains. The secondary-phase precipitates or ceramic nanoparticles have an average longest dimension of 2.0 micron or less. The microstructure can be produced by one or more equal-channel high-strain processes.Type: ApplicationFiled: November 15, 2016Publication date: March 2, 2017Inventor: Jacob Drew Edick
-
Patent number: 9522220Abstract: A bioerodible endoprosthesis includes a bioerodible magnesium alloy including between 50 weight percent and 92 weight percent magnesium, at least 5.5 weight percent in sum of one or more elements selected from the group consisting of Ho, Er, Lu, Tb and Tm, and at least 2.0 weight percent in sum of one or more elements selected from the group consisting of Y, Nd and Gd. The bioerodible magnesium alloy has a microstructure including equiaxed Mg-rich solid solution-phase grains having an average grain diameter of less than or equal to 15 microns and second-phase precipitates and/or ceramic nanoparticles in grain boundaries between the equiaxed Mg-rich solid solution-phase grains. The secondary-phase precipitates or ceramic nanoparticles have an average longest dimension of 2.0 micron or less. The microstructure can be produced by one or more equal-channel high-strain processes.Type: GrantFiled: October 29, 2014Date of Patent: December 20, 2016Assignee: Boston Scientific SciMed, Inc.Inventor: Jacob Drew Edick
-
Patent number: 9446174Abstract: A bioerodible endoprosthesis includes a composite including a matrix comprising a bioerodible magnesium alloy and a plurality of ceramic nanoparticles within the matrix. The bioerodible magnesium alloy has a microstructure including equiaxed Mg-rich solid solution-phase grains having an average grain diameter of less than or equal to 5 microns. The microstructure can be produced by one or more equal-channel high-strain processes.Type: GrantFiled: August 11, 2014Date of Patent: September 20, 2016Assignee: Boston Scientific SciMed, Inc.Inventors: Jan Weber, Jacob Drew Edick
-
Publication number: 20160263288Abstract: A bioerodible endoprosthesis includes a bioerodible body including an alloy comprising at least 85 weight percent magnesium and at least one high-melting-temperature element having a melting temperature of greater than 700° C. The alloy has a microstructure including equiaxed magnesium-rich phase grains and optionally high-melting-temperature intermetallic phases. The equiaxed magnesium-rich phase grains have an average grain diameter of less than or equal to 10 microns. High-melting-temperature intermetallic phases, if present, can have an average longest dimension of 3 microns or less.Type: ApplicationFiled: March 11, 2016Publication date: September 15, 2016Applicant: Boston Scientific Scimed, Inc.Inventors: Jacob Drew Edick, Jonathan S. Stinson
-
Publication number: 20150297382Abstract: A stent delivery catheter comprising at least one catheter shaft, the catheter shaft having an inner surface and an outer surface and a distal end and a proximal end, the catheter shaft defining a guidewire lumen, the guidewire lumen comprising a diameter defined by the inner surface of the catheter shaft, a stent disposed within the distal end of the catheter shaft and in contact with the inner surface of the catheter shaft, and a stylet disposed within the distal end of the catheter shaft, the stylet comprising a wave geometry.Type: ApplicationFiled: April 20, 2015Publication date: October 22, 2015Applicant: Boston Scientific Scimed Inc.Inventors: Anthony Frank Tassoni, JR., Martin R. Willard, Patrick A. Haverkost, Jonathan S. Stinson, Peter G. Edelman, Jacob Drew Edick
-
Publication number: 20150157767Abstract: A bioerodible endoprosthesis includes a bioerodible magnesium alloy including between 50 weight percent and 92 weight percent magnesium, at least 5.5 weight percent in sum of one or more elements selected from the group consisting of Ho, Er, Lu, Tb and Tm, and at least 2.0 weight percent in sum of one or more elements selected from the group consisting of Y, Nd and Gd. The bioerodible magnesium alloy has a microstructure including equiaxed Mg-rich solid solution-phase grains having an average grain diameter of less than or equal to 15 microns and second-phase precipitates and/or ceramic nanoparticles in grain boundaries between the equiaxed Mg-rich solid solution-phase grains. The secondary-phase precipitates or ceramic nanoparticles have an average longest dimension of 2.0 micron or less. The microstructure can be produced by one or more equal-channel high-strain processes.Type: ApplicationFiled: October 29, 2014Publication date: June 11, 2015Inventor: Jacob Drew Edick
-
Publication number: 20150066135Abstract: A bioerodible endoprosthesis includes a composite including a matrix comprising a bioerodible magnesium alloy and a plurality of ceramic nanoparticles within the matrix. The bioerodible magnesium alloy has a microstructure including equiaxed Mg-rich solid solution-phase grains having an average grain diameter of less than or equal to 5 microns. The microstructure can be produced by one or more equal-channel high-strain processes.Type: ApplicationFiled: August 11, 2014Publication date: March 5, 2015Inventors: Jan Weber, Jacob Drew Edick
-
Publication number: 20140236284Abstract: A bioerodible endoprosthesis includes a bioerodible magnesium alloy. The bioerodible magnesium alloy has a microstructure including equiaxed Mg-rich solid solution-phase grains having an average grain diameter of less than or equal to 5 microns and second-phase precipitates in grain boundaries between the equiaxed Mg-rich solid solution-phase grains. The beta-phase precipitates have an average longest dimension of 0.5 micron or less. The microstructure can be produced by one or more equal-channel high-strain processes.Type: ApplicationFiled: February 12, 2014Publication date: August 21, 2014Applicant: BOSTON SCIENTIFIC SCIMED, INC.Inventors: Jonathan S. Stinson, Dennis A. Boismier, Jacob Drew Edick, Torsten Scheuermann, Louis Toth, Jan Webber, Charles Deng